Viewing data from:

BETAMETHASONE VALERATE

ANDA

BETAMETHASONE VALERATE | A078337 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

API Supply Chain5 active DMFs8 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVBETAMETHASONE VALERATE

DMF 41181981

FARMABIOS SPABETAMETHASONE VALERATE

DMF 127491997

HALCYON LABS PRIVATE LTDBETAMETHASONE VALERATE USP

DMF 213202008

HENAN LIHUA PHARMACEUTICAL CO LTDBETAMETHASONE VALERATE

DMF 358652022

ZHEJIANG XIANJU PHARMACEUTICAL CO LTDBETAMETHASONE VALERATE

DMF 380632023

GLAXOCHEM LTDInactiveBETAMETHASONE VALERATE

DMF 45781982

COMPANIA ESPANOLA DE SINTESIS QUIMICA SAInactiveBETAMETHASONE VALERATE USP XX

DMF 54651984

DIOSYNTH BVInactiveBETAMETHASONE VALERATE

DMF 55541984

SCHERING AGInactiveBETAMETHASONE VALERATE

DMF 58631985

PFIZER INCInactiveBETAMETHASONE VALERATE

DMF 64051986

QUATRUMInactiveBETAMETHASONE VALERATE

DMF 70491987

HOECHST MARION ROUSSEL SAInactiveBETAMETHASONE VALERATE USP, BP

DMF 73101988

MAHIMA LIFE SCIENCES PRIVATE LTDInactiveBETAMETHASONE VALERATE USP

DMF 226512008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Nov 28, 2012	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.12%

0 patents0 exclusivities▴

AEROSOL, FOAM;TOPICAL | Approved: Nov 26, 2012

No patent or exclusivity listings for this strength.